WO2009004792A1 - スルホンアミド化合物及びその結晶 - Google Patents

スルホンアミド化合物及びその結晶 Download PDF

Info

Publication number
WO2009004792A1
WO2009004792A1 PCT/JP2008/001720 JP2008001720W WO2009004792A1 WO 2009004792 A1 WO2009004792 A1 WO 2009004792A1 JP 2008001720 W JP2008001720 W JP 2008001720W WO 2009004792 A1 WO2009004792 A1 WO 2009004792A1
Authority
WO
WIPO (PCT)
Prior art keywords
crystal
sulfonamide compound
monohydrochloride
thetav
isoquinolinesulfonyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/JP2008/001720
Other languages
English (en)
French (fr)
Inventor
Hitoshi Kida
Koki Matsubara
Shunsuke Kaneko
Yoshihito Kanzawa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Asahi Kasei Pharma Corp
Original Assignee
Asahi Kasei Pharma Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asahi Kasei Pharma Corp filed Critical Asahi Kasei Pharma Corp
Priority to ES08790119T priority Critical patent/ES2396795T3/es
Priority to AU2008272396A priority patent/AU2008272396B2/en
Priority to JP2009521521A priority patent/JP5234825B2/ja
Priority to CN2008800206312A priority patent/CN101730690B/zh
Priority to EP08790119A priority patent/EP2179997B1/en
Priority to KR1020097025553A priority patent/KR101246392B1/ko
Priority to HK10107571.0A priority patent/HK1141028B/xx
Priority to CA2690753A priority patent/CA2690753C/en
Publication of WO2009004792A1 publication Critical patent/WO2009004792A1/ja
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/472—Non-condensed isoquinolines, e.g. papaverine
    • A61K31/4725—Non-condensed isoquinolines, e.g. papaverine containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

　緑内障などの予防及び／又は治療のための医薬の有効成分として優れた性質を有する（Ｓ）－１－（４－クロロ－５－イソキノリンスルホニル）－３－（メチルアミノ）ピロリジン・１塩酸塩及びその結晶、並びに粉末Ｘ線回折スペクトルにおいて、２θが約１３．９°、２１．５°、２１．７°、２２．４°、２２．８°、２４．５°、及び３５．０°からなる群から選ばれる１以上の位置に主たるピークを有する上記１塩酸塩結晶。
PCT/JP2008/001720 2007-07-02 2008-07-01 スルホンアミド化合物及びその結晶 Ceased WO2009004792A1 (ja)

Priority Applications (8)

Application Number Priority Date Filing Date Title
ES08790119T ES2396795T3 (es) 2007-07-02 2008-07-01 Compuesto de sulfonamida y cirstal del mismo
AU2008272396A AU2008272396B2 (en) 2007-07-02 2008-07-01 Sulfonamide Compound and Crystal Thereof
JP2009521521A JP5234825B2 (ja) 2007-07-02 2008-07-01 スルホンアミド化合物及びその結晶
CN2008800206312A CN101730690B (zh) 2007-07-02 2008-07-01 磺酰胺化合物及其结晶
EP08790119A EP2179997B1 (en) 2007-07-02 2008-07-01 Sulfonamide compound, and crystal thereof
KR1020097025553A KR101246392B1 (ko) 2007-07-02 2008-07-01 술폰아미드 화합물 및 그 결정
HK10107571.0A HK1141028B (zh) 2007-07-02 2008-07-01 磺酰胺化合物及其结晶
CA2690753A CA2690753C (en) 2007-07-02 2008-07-01 Sulfonamide compound and crystal thereof

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP2007174323 2007-07-02
JP2007-174323 2007-07-02
US3422208P 2008-03-06 2008-03-06
US61/034,222 2008-03-06

Publications (1)

Publication Number Publication Date
WO2009004792A1 true WO2009004792A1 (ja) 2009-01-08

Family

ID=40225857

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2008/001720 Ceased WO2009004792A1 (ja) 2007-07-02 2008-07-01 スルホンアミド化合物及びその結晶

Country Status (9)

Country Link
US (2) US8232292B2 (ja)
EP (1) EP2179997B1 (ja)
JP (2) JP5234825B2 (ja)
KR (1) KR101246392B1 (ja)
CN (1) CN101730690B (ja)
AU (1) AU2008272396B2 (ja)
CA (1) CA2690753C (ja)
ES (1) ES2396795T3 (ja)
WO (1) WO2009004792A1 (ja)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2017513919A (ja) * 2014-04-28 2017-06-01 メッドシャイン ディスカバリー インコーポレイテッド Ｒｈｏキナーゼ阻害剤としてのイソキノリンスルホン誘導体
KR20200031669A (ko) * 2017-07-19 2020-03-24 차이나 리소시즈 파마수티컬 홀딩스 컴퍼니 리미티드 이소퀴놀리닐술포닐 유도체 및 이의 용도
WO2020129876A1 (ja) 2018-12-17 2020-06-25 株式会社デ・ウエスタン・セラピテクス研究所 イソキノリンスルホンアミドの新規な形態

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8415372B2 (en) * 2007-02-27 2013-04-09 Asahi Kasei Pharma Corporation Sulfonamide compound
JP5313125B2 (ja) * 2007-02-28 2013-10-09 旭化成ファーマ株式会社 スルホンアミド誘導体
WO2009004792A1 (ja) * 2007-07-02 2009-01-08 Asahi Kasei Pharma Corporation スルホンアミド化合物及びその結晶
CN102099037A (zh) * 2008-07-25 2011-06-15 旭化成制药株式会社 含有磺酰胺化合物的稳定的水溶液组合物
US11535595B2 (en) * 2018-12-18 2022-12-27 D. Western Therapeutics Institute, Inc. Isoquinoline sulfonyl chloride acid addition salts and method of manufacture thereof

Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57156463A (en) * 1981-03-20 1982-09-27 Asahi Chem Ind Co Ltd Isoquinoline derivative
JPS57200366A (en) * 1981-06-01 1982-12-08 Asahi Chem Ind Co Ltd Isoquinoline compound
JPS62111981A (ja) * 1985-11-12 1987-05-22 Asahi Chem Ind Co Ltd 環状のイソキノリンスルホンアミド誘導体
JPH02256666A (ja) * 1988-12-26 1990-10-17 Hiroyoshi Hidaka アルキレンジアミン誘導体及びその製造方法
JPH06100540A (ja) * 1992-09-24 1994-04-12 Asahi Chem Ind Co Ltd ５−イソキノリンスルホン酸アミド誘導体
JPH1087491A (ja) * 1996-07-26 1998-04-07 Asahi Chem Ind Co Ltd 転写調節因子阻害剤
WO2004076441A1 (ja) * 2003-02-28 2004-09-10 Kowa Co., Ltd. 多酸性塩基化合物の酸付加塩の製造方法
WO2007026664A1 (ja) 2005-08-30 2007-03-08 Asahi Kasei Pharma Corporation スルホンアミド化合物
JP2007238458A (ja) * 2006-03-06 2007-09-20 D Western Therapeutics Institute Inc 新規なイソキノリン誘導体及びこれを含有する医薬

Family Cites Families (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4456757A (en) 1981-03-20 1984-06-26 Asahi Kasei Kogyo Kabushiki Kaisha Isoquinolinesulfonyl derivatives and process for the preparation thereof
US5216150A (en) * 1988-12-26 1993-06-01 Hiroyoshi Hidaka Derivatives of isoquinoline (and naphthalene) sulfonamides
US5245034A (en) * 1988-12-26 1993-09-14 Kiroyoshi Hidaka Compound having vessel smooth muscle relaxation activity
CA2005741C (en) * 1988-12-26 1998-06-02 Hiroyoshi Hidaka Quinoline sulfonoamino compounds having vessel smooth muscle relaxation activity
JP3408546B2 (ja) 1991-02-19 2003-05-19 旭化成株式会社 抗喘息剤
FR2679907B1 (fr) 1991-07-31 1995-01-20 Adir Nouveaux n-[(isoquinolein-5 yl)sulfonyl] azacycloalcanes, leur procede de preparation et les compositions pharmaceutiques les contenant.
JP3176619B2 (ja) 1991-09-05 2001-06-18 ファルノ−ヴェトロファルム ゲゼルシャフト ミット ベシュレンクテル ハフツング 芳香族スルホンアミド化合物、阻害剤及びそれを含有する医薬組成物
PT868186E (pt) 1995-12-21 2005-05-31 Alcon Lab Inc Utilizacao de certos compostos de isoquinolinossulfonilo para tratamento de glaucoma e isquemia ocular
CA2240271C (en) 1995-12-21 2005-12-13 Alcon Laboratories, Inc. Use of certain isoquinolinesulfonyl compounds for the treatment of glaucoma and ocular ischemia
KR19990082174A (ko) 1996-02-02 1999-11-25 니뽄 신야쿠 가부시키가이샤 이소퀴놀린 유도체 및 의약
AU738620B2 (en) 1996-08-12 2001-09-20 Mitsubishi Pharma Corporation Pharmaceutical agent containing Rho kinase inhibitor
WO1999020620A1 (en) 1997-10-22 1999-04-29 Nippon Shinyaku Co Ltd Isoquinoline derivative and drug
CA2327276A1 (en) 1998-04-23 1999-10-28 Hiroshi Muramatsu Isoquinolinesulfonamide derivatives and drugs containing the same as the active ingredient
JP4212149B2 (ja) 1998-06-11 2009-01-21 株式会社デ・ウエスタン・セラピテクス研究所 医薬
US7217722B2 (en) * 2000-02-01 2007-05-15 Kirin Beer Kabushiki Kaisha Nitrogen-containing compounds having kinase inhibitory activity and drugs containing the same
MY142915A (en) 2001-03-23 2011-01-31 Bayer Healthcare Llc Rho-kinase inhibitors
DK1370553T3 (da) 2001-03-23 2006-09-11 Bayer Corp Rho-kinase-inhibitorer
JPWO2002100833A1 (ja) 2001-06-12 2004-09-24 住友製薬株式会社 Ｒｈｏキナーゼ阻害剤
US7094789B2 (en) * 2002-07-22 2006-08-22 Asahi Kasei Pharma Corporation 5-substituted isoquinoline derivatives
CA2493230A1 (en) 2002-07-22 2004-01-29 Asahi Kasei Pharma Corporation 5-substituted isoquinoline derivative
JP4482726B2 (ja) 2002-08-29 2010-06-16 参天製薬株式会社 Ｒｈｏキナーゼ阻害剤とプロスタグランジン類からなる緑内障治療剤
KR101160780B1 (ko) 2002-08-29 2012-06-27 산텐 세이야꾸 가부시키가이샤 Ｒｈｏ 키나아제 억제제 및 프로스타글란딘류를 포함하는 녹내장 치료제
CA2502583A1 (en) * 2002-09-12 2004-03-25 Kirin Beer Kabushiki Kaisha Isoquinoline derivatives having kinase inhibitory activity and medicament containing the same
EP1568382B1 (en) 2002-11-18 2013-11-06 Santen Pharmaceutical Co., Ltd. REMEDY FOR GLAUCOMA COMPRISING Rho KINASE INHIBITOR AND beta-BLOCKER
US7160894B2 (en) * 2003-06-06 2007-01-09 Asahi Kasei Pharma Corporation Tricyclic compound
GB0317315D0 (en) 2003-07-24 2003-08-27 Astex Technology Ltd Pharmaceutical compounds
JP2007008816A (ja) 2003-10-15 2007-01-18 Ube Ind Ltd 新規イソキノリン誘導体
JP2007015928A (ja) 2003-10-15 2007-01-25 Ube Ind Ltd 新規オレフィン誘導体
WO2005035506A1 (ja) 2003-10-15 2005-04-21 Ube Industries, Ltd. 新規インダゾール誘導体
JP2005232175A (ja) 2004-01-21 2005-09-02 Asahi Kasei Pharma Kk ５−置換イソキノリン医薬
CN1980929A (zh) * 2004-02-24 2007-06-13 比奥阿克松医疗技术股份有限公司 4－取代哌啶衍生物
US20060247266A1 (en) * 2004-11-26 2006-11-02 Asahi Kasei Pharma Corporation Nitrogen-containing tricyclic compounds
MY139797A (en) * 2004-11-29 2009-10-30 Kowa Co (s)-(-)-1-(4-fluoroisoquinolin-5-yl)sulfonyl-2-methyl-1, 4-homopiperazine hydrochloride dihydrate
WO2006105127A2 (en) * 2005-03-31 2006-10-05 Takeda San Diego, Inc. Hydroxysteroid dehydrogenase inhibitors
JP4257383B2 (ja) 2005-04-25 2009-04-22 株式会社デ・ウエスタン・セラピテクス研究所 高選択的Ｒｈｏキナーゼ阻害剤
WO2006115244A1 (ja) 2005-04-25 2006-11-02 D. Western Therapeutics Institute, Inc. ４－ブロモイソキノリン誘導体及びこれを含有する医薬
WO2006115245A1 (ja) 2005-04-25 2006-11-02 D. Western Therapeutics Institute, Inc. ４－エチニルイソキノリン誘導体及びこれを含有する医薬
JP2006348028A (ja) 2005-05-19 2006-12-28 Kowa Co 緑内障予防又は治療剤
KR101326425B1 (ko) 2005-06-21 2013-11-11 코와 가부시키가이샤 녹내장의 예방 또는 치료제
HRP20130876T1 (hr) 2005-07-12 2013-10-25 Kowa Company, Ltd. Sredstvo za prevenciju ili lijeäśenje glaukoma
US8415372B2 (en) 2007-02-27 2013-04-09 Asahi Kasei Pharma Corporation Sulfonamide compound
JP5313125B2 (ja) * 2007-02-28 2013-10-09 旭化成ファーマ株式会社 スルホンアミド誘導体
WO2009004792A1 (ja) * 2007-07-02 2009-01-08 Asahi Kasei Pharma Corporation スルホンアミド化合物及びその結晶

Patent Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57156463A (en) * 1981-03-20 1982-09-27 Asahi Chem Ind Co Ltd Isoquinoline derivative
JPS57200366A (en) * 1981-06-01 1982-12-08 Asahi Chem Ind Co Ltd Isoquinoline compound
JPS62111981A (ja) * 1985-11-12 1987-05-22 Asahi Chem Ind Co Ltd 環状のイソキノリンスルホンアミド誘導体
JPH02256666A (ja) * 1988-12-26 1990-10-17 Hiroyoshi Hidaka アルキレンジアミン誘導体及びその製造方法
JPH06100540A (ja) * 1992-09-24 1994-04-12 Asahi Chem Ind Co Ltd ５−イソキノリンスルホン酸アミド誘導体
JPH1087491A (ja) * 1996-07-26 1998-04-07 Asahi Chem Ind Co Ltd 転写調節因子阻害剤
WO2004076441A1 (ja) * 2003-02-28 2004-09-10 Kowa Co., Ltd. 多酸性塩基化合物の酸付加塩の製造方法
WO2007026664A1 (ja) 2005-08-30 2007-03-08 Asahi Kasei Pharma Corporation スルホンアミド化合物
JP2007238458A (ja) * 2006-03-06 2007-09-20 D Western Therapeutics Institute Inc 新規なイソキノリン誘導体及びこれを含有する医薬

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
AKIRA OGATA, KAGAKU JIKKEN SOSAHO, 20 November 1963 (1963-11-20), pages 381, 386 *
See also references of EP2179997A4

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2017513919A (ja) * 2014-04-28 2017-06-01 メッドシャイン ディスカバリー インコーポレイテッド Ｒｈｏキナーゼ阻害剤としてのイソキノリンスルホン誘導体
KR20200031669A (ko) * 2017-07-19 2020-03-24 차이나 리소시즈 파마수티컬 홀딩스 컴퍼니 리미티드 이소퀴놀리닐술포닐 유도체 및 이의 용도
KR102424348B1 (ko) 2017-07-19 2022-07-22 차이나 리소시즈 파마수티컬 홀딩스 컴퍼니 리미티드 이소퀴놀리닐술포닐 유도체 및 이의 용도
WO2020129876A1 (ja) 2018-12-17 2020-06-25 株式会社デ・ウエスタン・セラピテクス研究所 イソキノリンスルホンアミドの新規な形態
KR20210104729A (ko) 2018-12-17 2021-08-25 가부시키가이샤 디. 웨스턴 세라퓨틱스 겡큐쇼 이소퀴놀린술폰아미드의 신규한 형태
US11427546B2 (en) 2018-12-17 2022-08-30 D. Western Therapeutics Institute, Inc. Form of isoquinoline sulfonamide

Also Published As

Publication number Publication date
CA2690753C (en) 2013-08-13
JP5476436B2 (ja) 2014-04-23
HK1141028A1 (en) 2010-10-29
JP5234825B2 (ja) 2013-07-10
KR101246392B1 (ko) 2013-03-21
CN101730690A (zh) 2010-06-09
EP2179997B1 (en) 2012-11-14
US8232292B2 (en) 2012-07-31
ES2396795T3 (es) 2013-02-27
US8664243B2 (en) 2014-03-04
JP2012236858A (ja) 2012-12-06
CN101730690B (zh) 2013-01-16
AU2008272396A1 (en) 2009-01-08
US20120270898A1 (en) 2012-10-25
JPWO2009004792A1 (ja) 2010-08-26
CA2690753A1 (en) 2009-01-08
ES2396795T8 (es) 2013-03-13
EP2179997A4 (en) 2012-02-22
AU2008272396B2 (en) 2011-09-08
US20090156823A1 (en) 2009-06-18
KR20100017698A (ko) 2010-02-16
EP2179997A1 (en) 2010-04-28

Similar Documents

Publication Publication Date Title
WO2009004792A1 (ja) スルホンアミド化合物及びその結晶
WO2007027527A3 (en) Isoindole-imide compounds and compositions comprising and methods of using the same
WO2006053342A3 (en) Integrin antagonists useful as anticancer agents
WO2009053737A3 (en) Pyridine and pyrazine derivatives useful in the treatment of cell proliferative disorders
WO2007096151A3 (en) Inhibitors of p38-kinase for treatment of pulmonary hypertension
WO2008115516A8 (en) 4'-o-substituted isoindoline derivatives and compositions comprising and methods of using the same
WO2005121097A3 (en) Pyrazole derivatives, compositions containing such compounds and methods of use
WO2010026436A3 (en) 1,3, 4, 6, 7, 11b-hexahydro-benzo[alpha]quinolizines for the treatment of hyperkinetic movement and related disorders
WO2006112550A3 (en) A THERAPEUTIC AGENT FOR Aβ RELATED DISORDERS
WO2009061431A3 (en) Compositions for the treatment and prevention of eyelid swelling comprising an osmotically active ingredient and a vasoconstrictor
WO2006116148A3 (en) (7-arlysubstituted 2, 3-dihydr0-1-benz0furan-2-yl) alkylamines in the treatment' of substance abuse
WO2007143523A3 (en) Fused, tricyclic sulfonamide inhibitors of gamma secretase
WO2006066914A3 (en) Carbamate substituted imidazo- and pyrrolo-pyridines as protein kinase inhibitors
WO2007034312A3 (en) Pyridinaminosulfonyl substituted benzamides as inhibitors of cytochrome p450 3a4 (cyp3a4)
CA2527093A1 (en) 3-fluoro-piperidines as nmda/nr2b antagonists
IL187575A (en) Benzofuranyl derivatives ,pharmaceutical formulations comprising the same and use thereof in the preparation of medicaments for the treatment of 5-ht6-receptor related disorders
TW200531688A (en) Novel pentafluorosulfanyl compounds, their manufacture and use as pharmaceutical agents
EP2332526A3 (en) Combination of a renin-inhibitor and an anti-dyslipidemic agent and/or an antiobesity agent
WO2008004100A9 (en) Therapeutic compounds
WO2006034480A3 (en) Sulfonamide bicyclic compounds
UA87312C2 (ru) КОМПОЗИЦИЯ ДЛЯ АЭРОЗОЛЬНОЙ ИНГАЛЯЦИИ β-АГОНИСТОВ
WO2006108488A8 (en) Tricyclic azole derivatives, their manufacture and use as pharmaceutical agents
WO2006091836A8 (en) Formulations of ladostigil tartrate
WO2005082413A3 (en) Ciclesonide and glycopyrronium combination
WO2006130726A3 (en) Use of ladostigil for the treatment of multiple sclerosis

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 200880020631.2

Country of ref document: CN

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08790119

Country of ref document: EP

Kind code of ref document: A1

ENP Entry into the national phase

Ref document number: 20097025553

Country of ref document: KR

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 2690753

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 2009521521

Country of ref document: JP

WWE Wipo information: entry into national phase

Ref document number: 2008272396

Country of ref document: AU

Ref document number: 2008790119

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: DE

ENP Entry into the national phase

Ref document number: 2008272396

Country of ref document: AU

Date of ref document: 20080701

Kind code of ref document: A